Mortality in cardiogenic shock is stronger associated to clinical factors than contemporary biomarkers reflecting neurohormonal stress and inflammatory activation.
Jakob JosiassenMartin FrydlandLene HolmvangOle Kristian Lerche HelgestadLisette Okkels JensenJens Peter GoetzeJacob Eifer MøllerChristian HassagerPublished in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals (2020)
Plasma concentrations of Copeptin, MRproADM and proANP were associated with the IABP-SHOCK II risk score in STEMI patients admitted with CS. The risk score predicted 30-day mortality, with no improvement in prediction when concentrations of the assessed biomarkers were added.